FORMULATIONS OF RALTEGRAVIR
The present invention is directed to compressed tablets for oral administration, which comprise an intragranular component comprising the potassium salt of raltegravir, an inert superdisintegrant, and a binder; and an extragranular component comprising a superdisintegrant and a lubricant.
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French German |
Published |
23.03.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention is directed to compressed tablets for oral administration, which comprise an intragranular component comprising the potassium salt of raltegravir, an inert superdisintegrant, and a binder; and an extragranular component comprising a superdisintegrant and a lubricant. |
---|---|
Bibliography: | Application Number: EP20190814132 |